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Abstract A cholinergic neuroblastoma X glioma hybrid cell line 
NG108-15 is able to form functional synapses, and contains both 
AChR-aggregating and AChR-inducing activities when co-
cultured with myotubes. Several lines of evidence indicate that 
the AChR-inducing activity of NG108-15 cells is derived from 
neuregulin. The conditioned medium of cultured NG108-15 cells 
induced the expression of AChR a-subunit as well as the tyrosine 
phosphorylation of erbB-3 receptor. NG108-15 cells expressed 
neuregulin with a protein of ~ 100 kDa in size and transcripts of 
~6 .8 kbp, <~2.6 kbp and ~1 .8 kbp; mRNAs encoding pi and 
a2 isoforms of neuregulin were revealed. NG108-15 cells were 
induced to differentiate by chemicals, and the chemical-induced 
differentiation of NG108-15 cells increased the level of 
neuregulin mRNA expression ~ 3-fold while the expression of 
a housekeeping gene remained relatively unchanged. The activity 
of neuregulin in the conditioned medium of NG108-15 cells was 
reduced by treating the medium with heparin and anti-neuregulin 
antibody. In addition, NG108-15 cells were transfected with 
antisense neuregulin cDNA and its expression of neuregulin was 
reduced, while its neuregulin-induced tyrosine phosphorylation 
activity was markedly decreased. This is the first direct 
demonstration that the NG108-15 cell-induced AChR up-
regulation on cultured myotubes is mediated by neuron-derived 
neuregulin. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
During the formation of vertebrate neuromuscular junc-
tions, motor neurons make contact with muscle fibers and 
direct the formation of postsynaptic specializations [1]. These 
specializations include the aggregation of acetylcholine recep-
tors (AChRs), acetylcholinesterase (AChE) and other synaptic 
proteins. The increase in postsynaptic AChR density, up to 
approximately 10000 receptors/um2, is primarily due to the 
aggregation of AChRs already present on the membrane at 
the time of nerve-muscle contact as well as an increase in local 
AChR synthesis [1]. The aggregation of AChRs is induced by 
agrin derived from the presynaptic terminus [1^1]. In the local 
synthesis of RNAs encoding AChR subunits, AChE and other 
synapse-specific proteins are highly concentrated in the syn-
aptic regions [1,5,6]. The up-regulation of AChR synthesis at 
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the neuromuscular junction is induced by innervated motor 
neurons. The motor nerve provides two distinct mechanisms 
to achieve this striking localization of AChRs: (i) it releases 
factors, such as calcitonin gene-related peptide [7], ascorbic 
acid [8] and acetylcholine receptor inducing activity (ARIA) 
[9], that stimulate the synaptic expression of AChR; and (ii) 
nerve-evoked electrical activity represses the synthesis of 
AChR in the extrasynaptic regions [10]. 
ARIA, first isolated from chick brain, is the best candidate 
for the nerve-derived signal for postsynaptic gene regulation. 
ARIA could mimic several effects of motor axons on the 
muscle target that include: inducing the synthesis of AChR 
in aneural myotubes [9,11], increasing the number of voltage-
gated sodium channels [12] and the expression of the e-subunit 
of AChR characteristic of the adult AChR [13-15]. The 
ARIA's signaling pathway in muscle is mediated by erbB-2 
and/or erbB-3 receptors [15-17]. It is believed that ARIA 
released from the developing motor nerve terminals activates 
its receptor on the postsynaptic muscle membrane and induces 
the postsynaptic gene expression at the neuromuscular junc-
tion [9,18,19]. 
The chick ARIA cDNA encodes a considerably larger 
transmembrane precursor designated pro-ARIA with a pre-
dicted protein of 602 amino acids [11]. From N- to C-termi-
nus, pro-ARIA has immunoglobulin (Ig)-like, epidermal 
growth factor (EGF)-like, hydrophobic and intracellular do-
mains [11]. Mature ARIA of 42 kDa in size is believed to be 
produced by proteolytic cleavage of pro-ARIA at the K205 
and R2o6 dibasic amino acid residues adjacent to the hydro-
phobic domain [11]. Sequence analysis shows that ARIA be-
longs to the neuregulin family, which has diverse functions in 
neural development [20,21]. Members of neuregulin include 
rat neu differentiation factor [22], human heregulin [23] and 
bovine glial growth factor [24]. Thus, the term neuregulin has 
been used to describe all splice variations observed for this 
family [21,24]. Through alternative RNA splicing, many iso-
forms are generated from this family; the most common splic-
ing site is at the C-terminus of the EGF-like domain that 
determines two major classes of isoforms termed a and (3. 
Within each class, there are subclasses that are classified ac-
cording to the region downstream of the intracellular domain 
[22,23]. However, the full biological activity of neuregulin is 
restricted at the EGF-like domain [18,15,25]. 
A study model for in vitro synaptogenesis is the co-culture 
of myotube with a neuroblastoma X glioma hybrid cell line 
NG108-15 that was derived by somatic cell hybridization 
[26]. Apart from the formation of functional synapses with 
myotubes, several lines of evidence indicate that NG108-15 
cells are very similar to motor neurons. The differentiated 
NG108-15 cells are neuronal in light microscope appearance, 
have membranes of high electrical activity and capable of 
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generating acetylcholine-induced action potentials, have clus-
ters of synaptic vesicles, have a high level of acetylcholine 
transferase activity, and have agrin responsible for the 
A C h R aggregation when co-cultured with myotubes 
[3,26,27]. Although AChR-inducing activity has been reported 
in the cultured NG108-15 cells [28], the nature of that activity 
is not known. In order to establish the NG108-15 cell-myo-
tube co-culture system, we used molecular genetic approaches 
to show that NG108-15 cells expressed neuregulin and its 
activity could be blocked by heparin, antibody and antisense 
c D N A transfection. 
2. Materials and methods 
2.1. Cell cultures 
Neuroblastoma X glioma NG108-15 hybrid cells were cultured in 
100 mm culture dishes as described by [28]. NG108-15 cells were 
induced to differentiate by treatment with one of the following media 
supplemented with 1 mM JV6,02,-dibutyryladenosine 3',5'-cyclic 
monophosphate (Bt2-cAMP; Sigma, St. Louis, MO), 10 |xM prosta-
glandin El (PGE1; Sigma) and 1 mM theophylline, 1.5% (v/v) dime-
thylsulfoxide (DMSO; Sigma), or serum starvation. After 2 days of 
treatment, cells were washed and harvested for RNA or protein ex-
traction. 
Primary chick myotube cultures were prepared from the hind-limb 
muscles dissected from embryonic day 11 chick embryos. The muscles 
were then dissociated according to the modified protocol previously 
described [29]. Muscle cells were cultured in MEM supplement with 
10% heat inactivated horse serum, 2% (v/v) chick embryo extract, 
1 mM L-glutamine, 100 U/ml penicillin and 100 ug/ml streptomycin. 
In the co-cultures, NG108-15 cells were plated onto the 3-day-old 
chick myotubes in a 35 mm tissue culture plate for 2 days. The cells 
were rinsed with phosphate-buffered saline (PBS) pH 7.6, and used for 
immunohistochemical analysis. The C2C12 myoblasts were cultured 
and induced to fuse by reducing the serum to 1.5% [15]. All tissue 
culture chemicals were from Gibco-BRL (New York). 
2.2. Induction of AChR a-subunit 
In the AChR a-subunit induction assay, the chick myotubes were 
treated with conditioned medium of NG108-15 cells overnight, and 
total RNA was collected. Total RNA was electrophoresed in a 1% 
formaldehyde-agarose gel and transferred overnight onto a nylon 
membrane and hybridized with a [32P]dCTP-labeled cDNA probe of 
~ 1.2 kbp chick AChR a-subunit [30]. 
The pnlac Z plasmid containing 850 bp chick AChR a-subunit 
promoter tagged with P-galactosidase gene was described in [31] and 
provided by Dr. Joshua Sanes from Washington University School of 
Medicine. The cDNA was transfected into 2-day-old chick myotube 
cultures by using calcium phosphate precipitation [32]. Two days after 
transfection, the myotubes were cultured with NG108-15 cells for 36-
48 h. In p-galactosidase staining, cell cultures were fixed for 5 min in 
PBS containing 2% paraformaldehyde and 0.2% glutaraldehyde at 
room temperature, and then rinsed with PBS. The staining reaction 
was developed for 16-24 h at 37°C in PBS, pH 7.6, containing 1 mg/ 
ml X-Gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocya-
nide and 2 mM MgC^. After the color development, the culture was 
fixed with ethanol and observed under a Zeiss Axiophot microscope. 
2.3. Immunochemical analysis 
The cultured NG108-15 cell was fixed and stained by an anti-neu-
regulin antibody (a and P isoform-specific), then followed by fluores-
cent-conjugated secondary antiserum as described in [30]. For West-
ern blot analysis, NG108-15 cells were lysed in 0.5% (w/v) SDS in 50 
mM phosphate buffer (pH 8.0) and the protein concentrations were 
determined [33]. About 0.5 mg of protein was immunoprecipitated by 
the anti-neuregulin antibody (a and P isoform-specific), followed by 
protein G precipitation. Samples were electrophoresed on a 7.5% pol-
yacrylamide gel and transferred onto nitrocellulose membrane (MSI, 
Westborough, MA). The membranes were blocked with 5% (w/v) dry 
milk in 20 mM Tris base pH 7.6, 137 mM NaCl, 0.1% (v/v) Tween 20, 
for 1 h at 37°C, followed by incubation with anti-neuregulin antibody 
(a isoform-specific; 1:1000). Immunoreactivity was detected by ECL 
Western Blot System (Amersham, UK) following the instructions 
from the supplier. 
In the phosphorylation studies, fused C2C12 myotubes were treated 
with the conditioned medium from NG108-15 cells for 30 min [30]. 
The treated cells were resuspended in RIPA buffer (PBS pH 7.4, 1% 
NP-40, 0.5% deoxycholate, 0.1% SDS, 1 mM PMSF, 1 mM sodium 
orthovanadate, 1 mM aprotinin). The erbB-3 receptor was immuno-
precipitated with an antibody against erbB-3 (C17; Santa Cruz Bio-
tech., Santa Cruz, CA) at 1:1000 dilution. The immunoprecipitated 
proteins were collected on protein G agarose beads and fractionated 
by 7.5% SDS-PAGE [25,32]. Electrophoresed proteins were trans-
ferred onto nitrocellulose membrane. The membrane was blocked 
with buffer containing 2.5% BSA for 1 h at 37°C, followed by incu-
bation with horseradish peroxidase-conjugated anti-tyrosine phos-
phorylation antibodies RC 20 (Transduction Lab., Lexington, KY) 
diluted 1 in 1000. For the blocking of neuregulin, the conditioned 
medium was treated with heparin (50 ug/ml) or anti-neuregulin anti-
body (1:500 dilution) for 30 min before it applied onto the cultured 
C2C12 myotubes. Anti-neuregulin a isoform specific antibody was 
purchased from Transduction Lab. (Lexington, KY) and anti-neure-
gulin a and P isoform-specific antibody was raised in our laboratory 
by using the recombinant EGF-like domain of neuregulin as antigen 
[30]. 
2.4. RNA isolation and RT-PCR analysis 
Total RNA was isolated by using Micro RNA Isolation Kit (Stra-
tagene, CA, USA). RNA concentration and purity were determined 
by absorbance at 260 nm. In RT-PCR analysis, 5 ug of total RNAs 
was reverse transcribed by Moloney murine leukemia virus reverse 
transcriptase (Gibco-BRL) by random oligonucleotide priming in a 
20 ul reaction. One-fifth of the reverse transcription product was used 
as a template in PCR analysis with primers described below. PCR was 
carried out for 30 cycles of 94°C for 1 min, 60°C for 2 min and 72°C 
for 2 min in a 25 ul volume containing 0.8 mM dNTPs, IX PCR 
buffer and 0.625 U of Taq polymerase (Gibco-BRL). The PCR prod-
ucts were analyzed in a 12% polyacrylamide gel. The amplified DNAs 
were directly cloned into pCR II vector (Invitrogen, CA). The identity 
of the cloned PCR products was confirmed by DNA sequencing using 
T7 Sequencing kit (Pharmacia Biotech, Sweden). The PCR primers 
were designed according to rat neuregulin cDNA sequence [22]. Sets 
of primers flanking the EGF-like domain are S-l: 5'-GAC CTG TCA 
AAC CCG TCA AG-3' (sense; aa 937-956) and AS-1: 5'-AGC ACC 
CTC TTC TGG TAG AGT-3' (antisense; aa 1067-1047). 
2.5. Northern blot analysis 
RNA samples were fractionated on a 1% formaldehyde gel. Ethi-
dium bromide was used to assess the equal loading of different sam-
ples [32]. After the electrophoresis, samples were transferred to a 
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Fig. 1. The conditioned medium of NG108-15 cells induces the up-
regulation of AChR a-subunit mRNA synthesis in cultured myo-
tubes, but down-regulates in neuron-myotubes co-cultures. A: Four-
day-old chick myotubes were co-cultured with NG108-15 cells (co-
culture) for 1 day. Tetrodotoxin (TTX) at 1 uM was applied as a 
positive control, while the untreated myotube is the negative con-
trol. Total RNA was isolated from the cells and 10 ug of RNA was 
subjected to 1% formaldehyde-agarose gel. The membrane was 
probed with AChR a-subunit cDNA, and a transcript of ~3.2 kbp 
was detected. B: Like A except the myotubes were treated with the 
dialyzed NG108-15 cell conditioned medium (CM) for 1 day. Three 
independent experiments showed similar results. The lower panel 
shows the ribosomal RNA staining with 18S and 28S as markers. 
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charged nylon membrane (Hybond-N, Amersham, UK) and were UV 
cross-linked. Blots were hybridized with probes labeled with [rx-
32P]dCTP (Amersham) by Oligolabelling Kit (Pharmacia Biotech). 
Hybridization was performed at 42°C overnight in 40% deionized 
formamide, 5xDenhart 's solution, 0.5% SDS, 5XSSC, 10% dextran 
sulfate and 0.1 mg/ml denatured salmon sperm DNA. After hybrid-
ization, the filters were washed twice with 2XSSC with 0.1% SDS at 
room temperature for 30 min each, and then twice with O.lxSSC 
with 0.1% SDS at 55°C for 30 min each. The washed filters were 
exposed to X-ray film with double intensifying screens at —80°C. 
The cDNAs probes were: rat neuregulin (~0.5 kbp from 525-1060 
bp) [22], glyceraldehyde 3-phosphate dehydrogenase (~0.4 kbp) and 
chick AChR a-subunit ( ~ 1.2 kbp) [30]. 
2.6. cDNA construction and transfection 
The partial cDNA encoding rat neuregulin was cloned by RT-PCR 
with specific primers according to published sequences [22]. The pri-
mers were: 5'-ATC TTC GGC GAG ATG TCT GAG CG-3' (sense: 
325-347) and 5'-TCT TCT GGT AGA GTT CCT CCG C-3' (anti-
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Fig. 2. The conditioned medium or the co-culture of NG108-15 cells 
induces the expression of AChR a-subunit promoter. The pnlac Z 
plasmid containing 850 bp chick AChR a-subunit promoter tagged 
with |3-galactosidase gene was transfected into 2-day-old chick myo-
tube cultures by using calcium phosphate precipitation. Two days 
after transfection, the myotubes were either treated with NG108-15 
cell conditioned medium or co-cultured with NG108-15 cells for 
2 days. The P-galactosidase staining was developed. Blue color indi-
cates the induction of the promoter. A: pnlac Z transfected but 
without treatment. B: pnlac Z transfected and treated with the con-
ditioned medium. C: pnlac Z transfected and co-cultured with 
NG108-15 cells. Scale bar, 100 urn. 
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Fig. 3. Anti-neuregulin antibody recognized its antigen in differenti-
ated NG108-15 cell. NG108-15 cells cultured for 3 days were fixed 
and then permeabilized with 0.5% Triton X-100. Cells were stained 
with anti-neuregulin antibody (a and p isoform-specific), then fol-
lowed by FITC-conjugated secondary antibody. A: A phase of cul-
tured NG108-15 cell. B: Same view as A but with fluorescence op-
tic. A similar result was observed by using anti-neuregulin a 
isoform-specific antibody. Scale bar, 100 urn. 
sense: 1060-1039). The cloned product was confirmed by DNA se-
quencing. The pcDNA 3 plasmid (Invitrogen), containing a G418 
resistant gene and under control of a cytomegaloviral promoter, 
was used as a mammalian expression vector throughout this study. 
The cDNAs encoding neuregulin325-478 and neuregulins25-io60 were 
created by RT-PCR with artificial cloning sites at both ends. The 
cDNA inserts were silica-gel-purified (Geneclean II, Bio-101, La Jolla, 
CA) and ligated at the corresponding restriction enzyme site of 
pcDNA 3 for subcloning. The identity of cDNA constructs were 
confirmed by DNA sequencing. 
NG108-15 cells were transfected with calcium phosphate precipita-
tion and the transfection efficiency was consistently over 60%) [32]. For 
transient transfection, NG108-15 cells' conditioned medium was col-
lected 3 days after transfection [3]. 
3. Results 
3.1. AChR-inducing activity derived from NG108-15 cells 
When NG108-15 cells were co-cultured with chick myo-
tubes, the expression of AChR a-subunit mRNA was down-
regulated (Fig. 1A). The regulation of AChR by NG108-15 
cells in co-culturing with myotubes could be due to two fac-
tors: (i) the repression by secreted acetylcholine, (ii) the stim-
ulation by an unknown AChR-inducing factor(s). In order to 
discriminate the two opposing factors, the conditioned me-
dium of cultured NG108-15 cells was collected, dialyzed, 
and applied onto cultured chick myotubes. The AChR a-sub-
unit mRNA at ~3.2 kbp in the treated myotubes was in-
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creased ~5-fold (Fig. IB). When the pnlac Z plasmid con-
taining AChR oc-subunit promoter was transfected into cul-
tured myotubes, the conditioned medium or the co-culture of 
NG108-15 cells induced the expression of p-galactosidase 
staining on the transfected myotubes (Fig. 2). These results 
indicate the existence of a soluble AChR-inducing factor(s) 
that could be derived from the cultured NG108-15 cells. 
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3.2. Expression of neuregulin in NG108-15 cells 
In cultured NG108-15 cells, antibody against neuregulin 
recognized an antigen in the differentiated neurons. The cell 
body and the neurites were labeled (Fig. 3). Using cDNA 
encoding rat neuregulin as a probe in Northern blot analysis, 
three transcripts (~6.8 kbp, ~2 .6 kbp, ~1.8 kbp) were re-
vealed; the transcript below ~1.8 kbp represented the de-
graded product because it was not consistent in all samples 
(Fig. 4A). In contrast, a single transcript of ~7 .5 kbp and 
~6.5 kbp was detected in avian [11,30] and amphibian (Yang 
et a l , manuscript submitted) respectively. Differentiation of 
NG108-15 cells by either Bt2-cAMP, PGE1 and theophylline, 
or DMSO increased the level of neuregulin mRNA expression 
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Fig. 4. mRNAs encoding neuregulin are increased during the differ-
entiation of NG108-15 cells in culture. NG108-15 cells were induced 
to differentiate by different chemicals, such as Bt2-cAMP, DMSO, 
PGEl+theophylline (PGE1) and serum starvation (SS) for 3 days, 
then poly(A)+ RNAs were isolated from cultures. A: Neuregulin 
mRNAs were expressed at ~6.8 kbp, ~2.6 kbp and ~1.8 kbp as 
indicated. The expression of the transcripts were increased ~ 3 - to 
~ 4-fold after differentiation. The expression of glyceraldehyde 3-
phosphate dehydrogenase (lower panel), with a transcript size of 
~1.3 kbp as indicated, remained relatively unchanged. Control is 
the undifferentiated cells. B: RT-PCR was done with S-l and AS-2 
primers flanking the EGF-like domain of neuregulin. The PCR 
products were analyzed by a 12% acrylamide gel and stained by 
ethidium bromide. NG108-15 cells expressed predominantly pi and 
a2 neuregulin isoforms. Neuregulin (31 cDNA (NRGpl) serves as a 
positive control. Size markers in bp are shown. 
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Fig. 5. Inhibition of NG108-15 cell-induced erbB-3 tyrosine phos-
phorylation by heparin and anti-neuregulin antibody. The condi-
tioned medium of NG108-15 cells was treated with heparin (50 ug/ 
ml; CM+heparin), or anti-neuregulin antiserum (1:500 dilution; 
CM+anti-NRG) for 30 min before applied onto C2C12 myotubes. 
Conditioned medium (CM) or unconditioned medium (Control) 
served as controls. The treated myotubes were lysed in RIPA buffer. 
The erbB-3 receptor was immunoprecipitated with a 1:1000 dilution 
of a rabbit antibody (C17) against erbB-3. The immunoprecipitated 
proteins were collected on protein G agarose beads and fractionated 
by 7.5% SDS-PAGE. A: Electrophoresed proteins were transferred 
onto nitrocellulose membrane, and detected by peroxidase-conju-
gated anti-tyrosine phosphorylation antibodies RC 20 (upper panel), 
or by anti-erbB-3 antibody (lower panel). 200 kDa marker is shown. 
B: The amounts of protein recognized by antibody on an immuno-
blot were determined by densitometry. Arbitrary units from the den-
sitometer reading are used and the control phosphorylation is 1. 
Relative values are in mean±S.E.M., n = 4. 
~3.0- to ~ 4.0-fold (Fig. 4A). All transcripts were increased 
in similar magnitude in the chemical-induced differentiated 
NG108-15 cells. The expression level of the housekeeping 
gene glyceraldehyde 3-phosphate dehydrogenase, with a tran-
script size of ~1.3 kbp, remained relatively unchanged in 
differentiated NG108-15 cells (Fig. 4A) as reported previously 
[3]. Transcripts encoding various isoforms of neuregulin were 
analyzed by RT-PCR on RNAs isolated from NG108-15 cells. 
Two PCR products of 144 bp and 129 bp were revealed; they 
corresponded to pi and cc2 isoforms of neuregulin (Fig. 4B). 
However, the expression profile of pi and a2 isoforms of 
neuregulin was not affected in chemical-induced differentiated 
NG108-15 cells (Fig. 4B). 
3.3. The blocking of neuregulin activity from NG108-15 cells 
The conditioned medium of NG108-15 cells was applied 
onto cultured C2C12 myotubes; the tyrosine phosphorylation 
of erbB-3 receptor was increased (Fig. 5A). In order to deter-
mine the NG108-15 cell-induced tyrosine phosphorylation, in-
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Fig. 6. Transient transfection of neuregulin antisense cDNA reduces the tyrosine phosphorylation activity of NG108-15 cells. A: A map shows 
the location of antisense neuregulin (NRG) cDNA constructs. Open box is the coding region, bold line shows the non-coding regions, and nu-
cleotide numbers are in parentheses. The numbering is according to rat neuregulin cDNA as described in [22]. Two different antisense cDNA 
constructs were used: NGR325-478 and NRG525-io6o- Bar, 100 bp. B: Transfection of antisense neuregulin cDNAs reduces the expression of 
neuregulin in NG108-15 cells. Protein (~0.5 mg) from sense transfected control (S-NGR, including either S-NGR325_478 or S-NRG525_io6o), 
anti-sense transfected (AS-NGR325-478 and AS-NRG525-1060) and wild type NG108-15 cells were immunoprecipitated by anti-neuregulin anti-
body (a and B isoform-specific). The precipitated proteins were loaded onto a 7.5% SDS gel. Anti-neuregulin antibody (a isoform-specific) was 
used for the Western blot analysis. Two independent antibodies were used to confirm the specificity of the recognized 100 kDa as neuregulin. 
The antisense transfected stable cells show a reduction in ~100 kDa expression. Molecular weight markers are shown in kDa. C: Conditioned 
medium was collected from the transfected cells (sense control: S-NGR325-478 and S-NRG525_io60, and antisense transfected: AS-NGR325-478 
and AS-NRG525_io6o) o r control cells. They were applied onto cultured C2C12 myotubes. Tyrosine phosphorylation assay on the erbB-3 recep-
tor indicated that the neuregulin activity was decreased in the antisense transfected NG108-15 cells. The 200 kDa marker is indicated. 
deed, is mediated by neuregulin derived from the cultured 
neurons. The conditioned medium of NG108-15 cells was 
treated with heparin and anti-neuregulin antibody. Both 
agents are able to bind neuregulin [18,30]. Fig. 5B shows 
the tyrosine phosphorylation activity of the conditioned me-
dium is reduced by 60-70% by heparin and antibody respec-
tively. 
Whether neuregulin is the primary factor in NG108-15 cell-
induced AChR synthesis and tyrosine phosphorylation is not 
established. We used the antisense cDNA transfection ap-
proach to demonstrate directly the pivotal role of neuregulin 
in NG108-15 cells. Two regions of rat neuregulin cDNA were 
chosen for anti-sense cDNA construction. Fig. 6A shows the 
localization of antisense neuregulin cDNA constructs: 
NRG325-478 and NRG525-io60- Because of the low expression 
level of neuregulin in NG108-15 cells, anti-neuregulin anti-
body was used to immunoprecipitate the antigen from the 
cell lysate for the Western blot analysis. Transfection of anti-
sense neuregulin cDNAs (AS-NRG325-478 and AS-
NRG525-1060) in NG108-15 cells reduced the expression of 
neuregulin, at ~100 kDa, in NG108-15 cells as compared 
to the wild type or the sense transfected control NG108-15 
cells (Fig. 6B). The conditioned medium of the transfected 
NG108-15 cells was collected and tested for its erbB-3 recep-
tor phosphorylation analysis. The activity of NG108-15 cell-
induced tyrosine phosphorylation in antisense transfected cells 
was markedly reduced (Fig. 6C) indicating that neuregulin is 
the primary AChR-inducing factor in NG108-15 cells. 
4. Discussion 
Although AChR-inducing activity has been reported in the 
cholinergic neuroblastoma hybrid cell line NG108-15 [26,28], 
our results provide several lines of evidence to demonstrate 
that the AChR-inducing activity derived from NG108-15 cells 
is, indeed, neuregulin. First, the conditioned medium from 
NG108-15 cells increased the expression of AChR oc-subunit 
mRNA in cultured chick myotubes, and it stimulated the 
tyrosine phosphorylation of erbB-3 receptor in cultured 
C2C12 myotubes. Second, the cultured NG108-15 cells ex-
pressed antigen recognized by anti-neuregulin antibody. It 
also expressed mRNAs encoding neuregulin (~6.8 kbp, 
~2 .6 kbp, ~1.8 kbp) and they were up-regulated by chem-
ical-induced differentiation. Third, the activity of neuregulin 
in the conditioned medium of NG108-15 cells was blocked by 
treating the medium with heparin or anti-neuregulin antibody. 
Lastly, the antisense neuregulin cDNA transfection in 
NG108-15 cells reduced the expression of neuregulin, and 
that paralleled the decrease of tyrosine phosphorylation activ-
ity of the transfected neuronal cells. Although the neureguhn-
induced erbB receptor phosphorylation was blocked in the 
antisense cDNA transfection, other AChR-inducing activities 
derived from NG108-15 cell could be eliminated. 
In the antisense cDNA transfection, several attempts to 
create stable neuregulin-deficient NG108-15 cells have failed. 
The failure to obtain the stable transfectant may be due to 
vital, but not known, functional roles played by neuregulin in 
neuronal cells. Neuregulin has been reported to be mitogenic 
for a variety of cell types, such as Schwann cells and fibro-
blasts [24]. Recent studies have shown that antibodies against 
either erbB-2 or neuregulin reduced the proliferation of 
Schwann cells [34]. Moreover, neuregulin has been shown to 
promote the proliferation of blastema [35], and the differen-
tiation of various neuronal cells [34,36]. In molecular genetic 
analysis, knock-out mutations in mice have also shown that 
neuregulin [20], erbB-2 [37] and erbB-4 [38] are all lethal and 
they are essential for normal vertebrate development. 
Although NG108-15 cells in culture express pi and oc2 iso-
forms of neuregulin, both isoforms contain the full biological 
activity of neuregulin. Recent studies have demonstrated that 
the AChR-inducing activity of neuregulin requires only the 
EGF-like domain regardless of whether it is the a or (3 iso-
form [25,30]. In addition, mRNAs encoding neuregulin in 
NG108-15 cells were increased by chemical-induced differen-
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tiation. All transcripts showed an equal magnitude of re-
sponse. The up-regulation of neuregulin in differentiated 
NG108-15 cells could reflect a neuronal character of the cul-
tured cells. Indeed, the differentiated NG108-15 cells also 
showed an up-regulation of agrin mRNA and AChR-aggre-
gating activity when they were co-cultured with myotubes [3]. 
This distinct character of NG108-15 cells in up-regulating the 
expression of neuregulin and agrin could be a good model 
system to study the regulation mechanism of these synapse-
inducing molecules in neurons, in particular, information on 
this aspect is still lacking. 
Fischbach and his colleagues proposed that ARIA is re-
leased from the developing motor nerve terminals, activates 
its receptors on the postsynaptic muscle membrane and thus 
induces postsynaptic gene expression at the neuromuscular 
junctions [18]. In vertebrate neuromuscular junctions, three 
different cell types including neuron, muscle and Schwann 
cell could express neuregulin in vivo [6,13,30]. Although neu-
regulin is expressed in muscle and is regulated by innervation 
during development [30], it is not known whether the postsy-
naptic muscle fibers release their neuregulin to the synaptic 
cleft per se. Furthermore, whether muscle ARIA could play a 
role in the formation of postsynaptic specializations remains 
to be explained. In order to find evidence to support the 
'neuregulin release hypothesis' as proposed by Fischbach et 
al. [18], the antisense cDNA transfection could provide a use-
ful tool in elucidating the role of muscle-derived neuregulin in 
the formation of neuromuscular junctions. Although neuregu-
lin knock-out mutant mice were created, most of the origi-
nally attributed functions of neuregulin during the formation 
of neuromuscular junctions cannot be studied in these neureg-
ulin-deficient mice because of their early embryonic lethality. 
Thus, we are now creating neuregulin-deficient myotubes by 
antisense cDNA transfection in C2C12 cells and testing their 
response to the neuregulin-induced AChR up-regulation and 
tyrosine phosphorylation of erbB-3 receptor. This genetic ap-
proach has been shown to be successful in determining the 
roles of neuron-derived and muscle-derived agrin in inducing 
the AChR aggregation in the NG108-15 cell-myotube co-cul-
tures [3,4]. 
Functional synapses could be formed in NG108-15 cell-my-
otube co-cultures. Many aspects of NG108-15 cells are very 
similar to motor neurons in vitro: (i) they are both cholinergic 
in nature and form functional neuromuscular synapses when 
co-cultured with muscle cells [26,28]; (ii) both of them contain 
agrin as the primary AChR-aggregating factor that induces 
AChR aggregation in the neuron-muscle co-cultures [3]; (iii) 
both of them express neuregulin as the primary AChR-induc-
ing factor; and (iv) the AChE-inducing activity has also been 
reported in NG108-15 cells (Choi et al., manuscript submit-
ted). However, NG108-15 cells provide a better cell type as 
compared to motor neurons. The cultured NG108-15 cells are 
homogeneous, easy to culture, capable of being transfected 
with DNA to a high percentage of efficiency. Thus, the chol-
inergic neuronal nature of NG108-15 cells could replace mo-
tor neurons in neuron-muscle co-culture, and that could serve 
as an in vitro model system for the study of the formation of 
neuromuscular junctions. 
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